Abstract
Kinetic, dynamic, and metabolic data can be used to predict the appropriate studies, doses, duration, route of administration, species, and dosage interval in toxicology studies coordinated with drug development These data are used to predict starting and maximal doses in human studies, and when evaluated in conjunction with the data obtained in human pharmacokinetic studies, serve as an index for animal to human comparisons and extrapolations The optimal use of kinetic and dynamic information in standard pharmacologic and toxicologic studies will be presented. Reference will be made to problems encountered in the absence of these data and protocol development advantages where these data are incorporated. Development of pharmaceuticals, without incorporating kinetic and dynamic information, is currently associated with more costly, more time consuming, less utilizable knowledge and subsequent studies are often needed to explain anomalous results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Weissinger, J. (1993). Utility of Kinetic, Dynamic, and Metabolic Data in Nonclinical Pharmacology/Toxicology Studies. In: Yacobi, A., Skelly, J.P., Shah, V.P., Benet, L.Z. (eds) Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1520-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1520-0_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1522-4
Online ISBN: 978-1-4757-1520-0
eBook Packages: Springer Book Archive